tradingkey.logo
tradingkey.logo
Search

Kolon Tissuegene Highlights Long-Term Safety Data And Potential U.S. FDA Pathway For Tg-C At Oarsi World Congress

ReutersApr 28, 2025 1:53 PM
facebooktwitterlinkedin

- Kolon TissueGene Inc 950160.KQ:

  • KOLON TISSUEGENE HIGHLIGHTS LONG-TERM SAFETY DATA AND POTENTIAL U.S. FDA PATHWAY FOR TG-C AT OARSI WORLD CONGRESS

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

Tradingkey
KeyAI